NEURODEGENERATION

An Alzheimer’s-disease-protective APOE mutation

Article metrics

Homozygous APOE3-Christchurch (R136S) mutation protects a presenilin 1 (PSEN1) mutation carrier from developing Alzheimer’s disease until her seventies.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Effects of APOE3-R136S on Aβ and tau pathologies, neurodegeneration and cognition in PSEN1 mutation carriers, with potential underlying mechanisms.

References

  1. 1.

    Huang, Y. & Mucke, L. Cell 148, 1204–1222 (2012).

  2. 2.

    Quiroz, Y. T. et al. JAMA Neurol. 75, 548–556 (2018).

  3. 3.

    Acosta-Baena, N. et al. Lancet Neurol. 10, 213–220 (2011).

  4. 4.

    Arboleda-Velasquez, J. F. et al. Nat. Med. https://doi.org/10.1038/s41591-019-0611-3 (2019).

  5. 5.

    Mahley, R. W., Huang, Y. & Rall, S. C. Jr. J. Lipid Res. 40, 1933–1949 (1999).

  6. 6.

    Rauch, J. N. et al. Sci. Rep. 8, 6382 (2018).

  7. 7.

    Corder, E. H. et al. Science 261, 921–923 (1993).

  8. 8.

    Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Nat. Rev. Neurol. 9, 106–118 (2013).

  9. 9.

    Wang, C. et al. Nat. Med. 24, 647–657 (2018).

  10. 10.

    Najm, R., Jones, E. A. & Huang, Y. Mol. Neurodegener. 14, 24 (2019).

Download references

Author information

Correspondence to Yadong Huang.

Ethics declarations

Competing interests

Y. H. is a cofounder and scientific advisory board member of E-Scape Bio, Inc. and GABAeron, Inc. The other authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zalocusky, K.A., Nelson, M.R. & Huang, Y. An Alzheimer’s-disease-protective APOE mutation. Nat Med 25, 1648–1649 (2019) doi:10.1038/s41591-019-0634-9

Download citation